Stay updated on COTEZO IMblaze370 Clinical Trial
Sign up to get notified when there's something new on the COTEZO IMblaze370 Clinical Trial page.

Latest updates to the COTEZO IMblaze370 Clinical Trial page
- Check4 days agoChange DetectedA banner announces NIH’s transition-related updates and says that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content. It appears above the unavailable study record.SummaryDifference1%

- Check11 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating the study details are currently inaccessible. This suggests an access restriction or server-side issue preventing the study information from loading.SummaryDifference0.5%

- Check39 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the previous study record content and preventing access to the trial's details and resources. This indicates an access or server issue affecting the availability of the study information.SummaryDifference18%

- Check60 days agoChange DetectedNIH grant/contract funding detail was added to the study identifiers section, and the page revision label was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

Stay in the know with updates to COTEZO IMblaze370 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the COTEZO IMblaze370 Clinical Trial page.